Hepatocellular carcinoma |
Exosomal miR-1273f |
Increase angiogenesis |
Downregulate its target LHX6 |
69
|
Hepatocellular carcinoma |
Exosomal miR-23a/b |
Increase angiogenesis |
Target the von Hippel-Lindau/hypoxia-inducible factor axis |
70
|
Hepatocellular carcinoma |
Exosomal miR-155 |
Increase angiogenesis |
/ |
71
|
Oral Squamous Cell Carcinoma |
Exosomal miR-21 |
Increase the migration and invasion |
HIF-1 and HIF-2 increase the expression of miR-21 |
58
|
Bladder cancer |
Exosomal lncRNA-UCA1 |
Increase the migration and invasion |
LncRNA-UCA1 promotes tumor progression though EMT |
72
|
Oral Squamous Cell Carcinoma |
Exosomal miR-21 |
Regulate immune response |
Target PTEN/PD-L1 axis |
78
|
Nasopharyngeal carcinoma |
Exosomal miR-24-3p |
Regulate immune response |
Downregulate its target FGF11 |
79
|
Pancreatic cancer |
Exosomal miR-301a-3p |
Regulate immune response |
Target PTEN/PI3K axis |
84
|
Lung cancer |
Exosomal miR-103a |
Regulate immune response |
Target AKT/STAT3 axis |
85
|
Epithelial ovarian cancer |
Exosomal miR-940 |
Regulate immune response |
/ |
86
|
Lung cancer |
Exosomal TGF-β |
Regulate immune response |
Decrease the expression of NKG2D |
91
|